uniQure (QURE) Exchange Rate Effect (2016 - 2026)
uniQure's (QURE) quarterly Exchange Rate Effect came in at -$1.1 million in Q1 2026, down 168.19% year-on-year from $1.7 million in Q1 2025, and down 340.47% quarter-over-quarter from -$257000.0 in Q4 2025.
uniQure (QURE) Exchange Rate Effect (2016 - 2026) Analysis & Trends
uniQure's Exchange Rate Effect history runs 11 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 168.19% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 280.87% increase from a year earlier, with the FY2025 full-year figure at $5.7 million, up 213.85% from the prior year.
- Exchange Rate Effect slipped to -$1.1 million in Q1 2026 per QURE's latest filing, from -$257000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $10.0 million in Q4 2022 and bottomed at -$6.8 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$257000.0 (2025), against an average of -$588.24.
- Biggest YoY gain for Exchange Rate Effect was 960.02% in 2022; the steepest drop was 9264.44% in 2022.
- Year by year, Exchange Rate Effect stood at $10.0 million in 2022, then plunged by 81.67% to $1.8 million in 2023, then tumbled by 467.46% to -$6.8 million in 2024, then soared by 96.2% to -$257000.0 in 2025, then tumbled by 340.47% to -$1.1 million in 2026.
- Per Business Quant, the three latest QURE Exchange Rate Effect figures stand at -$1.1 million (Q1 2026), -$257000.0 (Q4 2025), and $862000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.13 Mn |
| Mar 31, 2026 | -1.13 Mn |
| Dec 31, 2025 | -257,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Sep 30, 2025 | 862,000.00 |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 3.39 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | -6.77 Mn |
| Dec 31, 2024 | -6.77 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Jun 30, 2024 | -466,000.00 |
| Jun 30, 2024 | -466,000.00 |
| Mar 31, 2024 | -1.73 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Dec 31, 2023 | 1.84 Mn |